A Phase II, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis With or Without Mesalamine [mesalazine].

Trial Profile

A Phase II, Randomized, Multi-Centre, Double-Blind, Placebo-Controlled Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis With or Without Mesalamine [mesalazine].

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2012

At a glance

  • Drugs HMPL 004; Mesalazine
  • Indications Ulcerative colitis
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 May 2012 EudraCT reports trial status as discontinued and inclusion-exclusion criteria amended.
    • 28 Apr 2012 Additional trial location added as reported by European Clinical Trials Database.
    • 28 Apr 2012 New source identified and integrated (EudraCT2007-005166-12: European Clinical Trials Database)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top